Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.
about
Metformin for treatment of clozapine-induced weight gain in adult patients with schizophrenia: a meta-analysisSafety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approachGender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medicationsMetformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis.Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK.Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study.Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials.The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis.A core outcome set for evaluating self-management interventions in people with comorbid diabetes and severe mental illness: study protocol for a modified Delphi study and systematic reviewSerum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis.Atypical antipsychotics: recent research findings and applications to clinical practice: Proceedings of a symposium presented at the 29th Annual European College of Neuropsychopharmacology Congress, 19 September 2016, Vienna, Austria.Diabetes mellitus and severe mental illness: mechanisms and clinical implications.Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.The prevention of diabetes and cardiovascular disease in people with schizophrenia.Type 2 diabetes in children and adolescents on atypical antipsychotics.Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia.Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review.Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes.Diabetes and Schizophrenia.BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.Managing comorbid obesity and depression through clinical pharmacotherapies.Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options.Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials.Antipsychotic-associated weight gain: management strategies and impact on treatment adherence.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care.Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment.Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
P2860
Q26747597-A5CB45F3-71C5-44DB-B148-E7D90722A90FQ33878816-56C457A8-B57F-419A-BB65-349FE688D5A3Q34248044-2CED0067-CC7C-46C0-AA44-CA9EC28ADE38Q34464293-C15E3D20-A2DA-4D5B-979C-E28B0DCCB6BAQ36060797-CAB8087E-8C9F-47BB-868C-8786F20A9FFCQ36156730-9403A10C-D28C-4FBF-8DF5-412DB7CD17C5Q36163545-8B4B34FC-4DEC-4367-93CB-50B8E6FEEFF2Q36223890-D190E93F-4D85-44D7-8489-F2120E5EB1F4Q36232038-28009E72-ED1B-4FB8-B81F-5FBBD00ABD56Q36240230-BB6CF40C-665E-4187-9161-8035FACFC8FBQ37642902-63CF93A2-BA3C-4EC5-BFAA-6CF8D721E476Q37648311-266AF7B0-D902-4CFE-888E-70ADC85A37E4Q37698621-9AA47681-FF30-4EF7-A8E8-0444EA3934D7Q38274901-C3089A49-665E-4D2B-92E5-4775F1ECFC6BQ38375731-16B31B16-D157-434C-852B-C9BDCAF25D0CQ38482029-44E00EEC-CD2E-419D-A624-E335EDD0E4C3Q38530458-9B36BA1F-FB3D-436F-B254-F8D23946042FQ38626655-84494138-76B6-457E-9419-1960FDF0D8EDQ38674637-764E4681-D5EC-4699-A47B-924DF765D9FAQ38708352-50FB20A7-8801-4F6D-93D6-B44893D7A703Q38709352-7DD40E87-9326-4456-A100-62B8B23D9EDAQ38826206-285B6A45-0F0B-43A3-9475-F312A3412719Q38859885-C2FC6DC7-A788-4CC8-B1C0-F2945700724AQ39404106-8D026A60-E501-4455-89DE-F33530BD31B1Q39441481-415E2666-0F9A-4A43-AB00-6DD9E4B1FA76Q41546064-649F3C48-E659-4E00-9F82-EF4CD2AFBC16Q47725026-3F6EA3DB-B47B-4A0F-BBD2-51C922D6BB4BQ47947938-31AEA590-4C57-46FB-97C2-B314465C3C4CQ50156396-1ECD7F21-0189-4EAC-9BC1-989880996496Q58768772-C0010894-E8AD-4C22-87CD-53C527A99393
P2860
Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacological strategies to ...... atic review and meta-analysis.
@ast
Pharmacological strategies to ...... atic review and meta-analysis.
@en
Pharmacological strategies to ...... atic review and meta-analysis.
@nl
type
label
Pharmacological strategies to ...... atic review and meta-analysis.
@ast
Pharmacological strategies to ...... atic review and meta-analysis.
@en
Pharmacological strategies to ...... atic review and meta-analysis.
@nl
prefLabel
Pharmacological strategies to ...... atic review and meta-analysis.
@ast
Pharmacological strategies to ...... atic review and meta-analysis.
@en
Pharmacological strategies to ...... atic review and meta-analysis.
@nl
P2093
P2860
P31
P921
P3181
P356
P1476
Pharmacological strategies to ...... atic review and meta-analysis.
@en
P2093
Hiroyuki Uchida
Kazunari Yoshida
Masaru Mimura
Takefumi Suzuki
Walter Wolfgang Fleischhacker
Yuya Mizuno
P2860
P304
P3181
P356
10.1093/SCHBUL/SBU030
P407
P577
2014-11-01T00:00:00Z